FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Clinical trial NCT04551885 · TERMINATED

Trial details

NCT number: NCT04551885
Sponsor: Fate Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2020-09-07
Primary completion: 2023-08-11
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.